HCA
ABBV icon

Harbor Capital Advisors’s AbbVie ABBV Stock Holding History

Harbor Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.49M Sell
20,658
-4,779
-19% -$1.06M 0.36% 48
2025
Q4 		$5.81M Sell
25,437
-37
-0.1% -$8.43K 0.45% 34
2025
Q3 		$5.9M Buy
25,474
+682
+3% +$139K 0.46% 33
2025
Q2 		$4.6M Sell
24,792
-142
-0.6% -$26.4K 0.19% 178
2025
Q1 		$5.22M Buy
+24,934
New +$4.85M 0.24% 149

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbor Capital Advisors's ABBV Position: Q1 2026 in Review

Harbor Capital Advisors reduced its AbbVie (ABBV) stake by 19% in Q1 2026, selling an estimated $1.06M and leaving 20,658 shares worth $4.49M. The position accounts for 0.36% of the portfolio, ranked #48.

Harbor Capital Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.9M in Q3 2025. 4,082 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Harbor Capital Advisors held 20,658 shares of AbbVie worth $4.49M as of Q1 2026.
  • Harbor Capital Advisors sold 4,779 AbbVie shares in Q1 2026, an estimated $1.06M.
  • AbbVie made up 0.36% of Harbor Capital Advisors's portfolio in Q1 2026, its #48 holding.
  • Harbor Capital Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Harbor Capital Advisors's AbbVie position peaked at $5.9M in Q3 2025.
  • 4,082 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.